Moreover, an RNA immunoprecipitation (RIP) assay using an ELAVL2 antibody confirmed the binding interaction between endogenous ELAVL2 and the SH3GL3 or DNM3 transcripts in ELAVL2-high GBM cells (Fig. 7e; bottom panel). The gene discussed is ELAVL2; the disease is glioblastoma.